Cargando…
Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Clinical Investigation
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718143/ https://www.ncbi.nlm.nih.gov/pubmed/34981780 http://dx.doi.org/10.1172/JCI155330 |
| _version_ | 1784624660499922944 |
|---|---|
| author | Kunos, George Jourdan, Tony Tam, Joseph |
| author_facet | Kunos, George Jourdan, Tony Tam, Joseph |
| author_sort | Kunos, George |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8718143 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society for Clinical Investigation |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87181432022-01-05 Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? Kunos, George Jourdan, Tony Tam, Joseph J Clin Invest Letter to the Editor American Society for Clinical Investigation 2022-01-04 2022-01-04 /pmc/articles/PMC8718143/ /pubmed/34981780 http://dx.doi.org/10.1172/JCI155330 Text en © 2022 Kunos et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Kunos, George Jourdan, Tony Tam, Joseph Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? |
| title | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? |
| title_full | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? |
| title_fullStr | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? |
| title_full_unstemmed | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? |
| title_short | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? |
| title_sort | do endocannabinoids acting via hepatic cb-1 contribute to nafld and hepatic insulin resistance? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718143/ https://www.ncbi.nlm.nih.gov/pubmed/34981780 http://dx.doi.org/10.1172/JCI155330 |
| work_keys_str_mv | AT kunosgeorge doendocannabinoidsactingviahepaticcb1contributetonafldandhepaticinsulinresistance AT jourdantony doendocannabinoidsactingviahepaticcb1contributetonafldandhepaticinsulinresistance AT tamjoseph doendocannabinoidsactingviahepaticcb1contributetonafldandhepaticinsulinresistance |